ReviewMediterranean journal of rheumatology2026

Emerging Targets in Psoriatic Arthritis: Dual IL-17A/F and Selective TYK2 Inhibition in a Clinical Perspective.

Violeta Dimopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.